Efficacy/Safety Study of Deferiprone Compared to Deferasirox in Paediatric Patients

NCT01825512 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

435

Enrollment

OTHER

Sponsor class

Conditions

Chronic Iron Overload

Interventions

DRUG: Deferiprone
DRUG: Deferasirox

Sponsor

Consorzio per Valutazioni Biologiche e Farmacologiche

Collaborators

[object Object]